Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Pharmacogenet Genomics. 2017 Mar;27(3):112–119. doi: 10.1097/FPC.0000000000000264

Table 2.

Most significantly associated SNPs

SNP Chr Position MA MAF OR 95% CI P-value Gene
rs2061538 17 77112562 G 0.16 1.52 1.3-1.7 6.2x10-09 RBFOX3
rs77370934 5 161604254 G 0.03 3.16 2.1-4.6 7.7x10-09 GABRG2
rs56209714 17 77113268 G 0.14 1.54 1.3-1.7 7.9x10-09 RBFOX3
rs192613545 16 28863901 T 0.07 2.33 1.7-3.1 2.5x10-08 SH2B1
chr17:77112502:I 17 77112502 C 0.14 1.62 1.3-1.9 2.7x10-08
rs62063838 17 77114028 C 0.17 1.47 1.2-1.6 3.7x10-08 RBFOX3
rs10946364 6 20177222 T 0.39 1.34 1.2-1.4 3.8x10-08 MBOAT1
rs56044629 17 77109653 G 0.14 1.51 1.3-1.7 4.2x10-08 RBFOX3

SNP: single nucleotide polymorphism, Chr: chromosome, MA: minor allele, MAF: minor allele frequency, OR: odds ratio, CI: confidence interval,

A List of the most significantly associated SNPs which reached P-value of less than 10-05 in meta-analysis, is available as the supplementary material.